AstraZeneca The Director, Medical Diagnostics Hematology ensures the timely, high quality input into development and lifecycle plans, to support optimal companion diagnostics / testing solutions to enable optimal treatment throughout the patient journey and to support patient access. This role is within US Medical Affairs supporting the Heme Oncology Franchise. An important element of this role is therefore to develop strategic and long-term partnerships with both internal and external oncology stakeholders and decision makers in the complex oncology ecosystem including with the core medical teams, development organization and global medical teams, based on a deep scientific understanding of the testing environment and the pathology of the tumor/micro-environment and the medical and clinical operational issues on the disease and testing pathway, enabling the organization to help develop tailored testing solutions to be developed for the US market. Equally important, the...

Boehringer Ingelheim Description As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees. The Sr. AD Medical Affairs Strategy [TA] serves as the subject matter expert to create the indication-specific or product-specific Medical strategic framework and prioritized Medical tactics to ensure the success of the respective BI product(s) from a Medical...

Boehringer Ingelheim Compensation Data This position offers a base salary typically between $167,000 and $289,000. The position may be eligible for a role specific variable or performance based bonus and or other compensation elements. For an overview of our benefits please click here. Description As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our...

Boehringer Ingelheim Description As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees. The Medical Affairs Strategy [TA] Director is responsible to create the Medical strategic framework and prioritized Medical tactics to ensure the success of the respective BI product(s) from a Medical Affairs perspective, both prior to and leading up to launch as...

Boehringer Ingelheim Description The Sr. AD Medical Affairs Strategy Dermatology serves as the subject matter expert to create the indication-specific or product-specific Medical strategic framework and prioritized Medical tactics to ensure the success of the respective BI product(s) from a Medical Affairs perspective, both prior to and leading up to launch as well as throughout the product lifecycle. This individual will bring together strong technical knowledge of the therapeutic area, strong command of the relevant clinical practice guidelines and related scientific data as well as the understanding of the overall TA priorities and value drivers into an integrated strategic medical plan and tactics that enable the successful medical affairs contribution to BI's portfolio and informs clinical development efforts where applicable. This individual will work with relevant stakeholders to drive integrated medical plans and executable tactics customized for organized customer...

AstraZeneca Do you have expertise in, and curiosity for leading Medical Affairs teams in Oncology ? Apply your experience to changing the way cancer is treated at AstraZeneca , a company that follows the science and turns ideas into life changing medicines. Help to advance our incredible pipeline by applying expertise and accelerating our pathway to finding a cure. A dedicated Oncology Business Unit (OBU), this is the place to build a best-in-class career. AstraZeneca's vision in Oncology is to help patients by redefining the cancer-treatment paradigm with the bold ambition to eliminate cancer as a cause of death. We are proud to work on ground-breaking science with one of the broadest and deepest Oncology pipelines in the business. Reporting to the Medical Head, the US Oncology Medical Affairs Group Medical Lead plays a pivotal role in channelling our scientific capabilities and strategy to make a positive impact on changing patients' lives. Join us at our dynamic site...

AstraZeneca At AstraZeneca we work together across global boundaries to make an impact and find answers to challenges. We do this with the utmost integrity even in the most difficult situations because we are committed to doing the right thing. We continuously forge partnerships that help pursue world-class medicines in new ways, combining our people's exceptional skills with those of people from all over the globe. The Oncology therapy area at AstraZeneca is unparalleled. We have built and strategically acquired one of the most promising Oncology pipelines in the industry. You will be among inspiring oncology industry leaders who will keep you engaged and empower you to be the best. We seek out opportunities to do dynamic and significant work which means we won't just follow the same course of action time and again if we can see potential in a different way of building life changing medicine. We share a collective sense of urgency - to defeat cancer and improve the lives...

argenx Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. This role is part of the Site and Patient Engagement team within Trial Operations at argenx. The Patient Recruitment & Retention Strategy Lead encompasses strategic leadership and oversight of patient recruitment efforts across...

argenx Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. It is an exciting time of growth for argenx as we strive to achieve our VISION 2030. Vision 2030 is our long-term commitment to transform the treatment of autoimmune diseases by strengthening our leadership in neonatal Fc receptor (FcRn)...

argenx Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. It is an exciting time of growth for argenx as we strive to achieve our VISION 2030. Vision 2030 is our long-term commitment to transform the treatment of autoimmune diseases by strengthening our leadership in neonatal Fc receptor (FcRn)...

argenx Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. It is an exciting time of growth for argenx as we strive to achieve our VISION 2030. Vision 2030 is our long-term commitment to transform the treatment of autoimmune diseases by strengthening our leadership in neonatal Fc receptor (FcRn)...

argenx Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. It is an exciting time of growth for argenx as we strive to achieve our VISION 2030. Vision 2030 is our long-term commitment to transform the treatment of autoimmune diseases by strengthening our leadership in neonatal Fc receptor (FcRn)...

argenx Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. It is an exciting time of growth for argenx as we strive to achieve our VISION 2030. Vision 2030 is our long-term commitment to transform the treatment of autoimmune diseases by strengthening our leadership in neonatal Fc receptor (FcRn)...

Biogen Job Description About This Role The Associate Director, Corporate Strategy & New Businesses Integration contributes to defining, prioritizing, evaluating, and pursuing strategic growth and value creating opportunities for Biogen. This role exposes the individual to cross-functional colleagues across the organization and requires strong collaboration and partnership in the assessment of both internal and external investment opportunities. You will help shape multi-faceted disease area strategies including exploration into new areas for growth. You will support and lead market landscape and asset-specific evaluations with an emphasis on objectivity. You will contribute to business case development to inform investment recommendations to senior decision makers. You will operate with entrepreneurial spirit and urgency to positively influence Biogen's ability to deliver new medicines to individuals across the globe afflicted by some of the most complex and challenging...

Novartis Job Description Summary This position will be located at the East Hanover, NJ or Cambridge, MA site and will not have the ability to be located remotely. This position will require 1% travel as defined by the business (domestic and/ or international). The Statistical Programming community at Novartis comprises of approximately 350 (internal) statistical programmers and belongs to the Advanced Quantitative Sciences (AQS) organization which also includes more than 450 biostatisticians, pharmacometricians and data scientists supporting the entire portfolio of clinical projects across the Research, Development and Commercial spectrum. In this role, you will be responsible for all statistical programming aspects of one or more drug development programs or indication programs. This role may involve being a people manager, a program lead, or both. In this role, you will lead cross-functional collaboration within and outside AQS and decision-making for assigned...

Novartis Job Description Summary This position will be located at the East Hanover, NJ or Cambridge, MA site and will not have the ability to be located remotely. This position will require 1% travel as defined by the business (domestic and/ or international). The Statistical Programming community at Novartis comprises of approximately 350 (internal) statistical programmers and belongs to the Advanced Quantitative Sciences (AQS) organization which also includes more than 450 biostatisticians, pharmacometricians and data scientists supporting the entire portfolio of clinical projects across the Research, Development and Commercial spectrum. In this role, you will be responsible for all statistical programming aspects of one or more drug development programs or indication programs. This role may involve being a people manager, a program lead, or both. In this role, you will lead cross-functional collaboration within and outside AQS and decision-making for assigned...

AstraZeneca At AstraZeneca, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality! If you are swift to action, confident to lead, willing to collaborate, and curious about what science can do, then you're our kind of person. As a Global Development Medical/Science Senior Director with a focus on Cardiovascular/Renal or Metabolic dysfunction (including Diabetes, Obesity and NASH/MASH) , you'll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients' lives. The successful Global Development Medical/Science Director in Late Phase CVRM (Cardiovascular, Renal, and Metabolic diseases) will be responsible for the design, conduct, monitoring, data interpretation and reporting of individual clinical trials ensuring that the clinical data collected within the study will allow determination of the benefits...

AstraZeneca At AstraZeneca, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality! If you are swift to action, confident to lead, willing to collaborate, and curious about what science can do, then you're our kind of person. As a Global Development Medical/Science Director with a focus on Cardiovascular/Renal or Metabolic dysfunction (including Diabetes, Obesity and NASH/MASH) , you'll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients' lives. The successful Global Development Medical/Science Director in Late Phase CVRM (Cardiovascular, Renal, and Metabolic diseases) will be responsible for the design, conduct, monitoring, data interpretation and reporting of individual clinical trials ensuring that the clinical data collected within the study will allow determination of the benefits and...

Novartis Job Description Summary #LI-Hybrid Location: Cambridge, MA or East Hanover, NJ About the role: Study Leader for complex global early-phase oncology trials Job Description Key Responsibilities: Study Leader and/or Clinical Scientist for predominantly high complexity, global studies. May function as a Core Project Team member for assigned projects to drive the Research-Development-Commercial (RDC) continuum. May co-lead project clinical sub-team and reports study/project progress and issues with their resolution plan to project teams and stakeholders. Directs early stages of study design and operational plans. Lead a global cross functional Clinical Trial Team (CTT) to ensure all trial deliverables are met; sets stretch goals, promotes realistic planning and timelines, and presents actionable alternatives to accelerate timelines. Proactively lead risk mitigation discussions, risk management and implementation at the trial level. Responsible and...

argenx Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. It is an exciting time of growth for argenx as we strive to achieve our VISION 2030. Vision 2030 is our long-term commitment to transform the treatment of autoimmune diseases by strengthening our leadership in neonatal Fc receptor (FcRn)...